Streetbeat News

Regulatory

AMD

INTC

NVDA

QCOM

QQQ

SPY

Intel is investing $300 million to expand its chip packaging and testing facility in Chengdu, China, despite cybersecurity concerns. This move strengthens Intel's ties with China, its largest market, and aims to enhance supply chain efficiency. The expansion comes amid challenges such as a decline in server market share and strategic considerations like potential mergers and acquisitions.

Portfolio Pulse from Anusuya Lahiri

October 29, 2024 | 2:14 pm

CME

CME Group has received approval from the National Futures Association (NFA) to establish a Futures Commission Merchant (FCM). This move is aimed at enhancing risk management and expanding client services.

Portfolio Pulse from Benzinga Newsdesk

October 29, 2024 | 2:06 pm

PLMJ

Tactical Resources Corp. and Plum Acquisition Corp. III have filed a Form F-4 Registration Statement with the SEC for their proposed business combination. This merger aims to create a new publicly traded entity, subject to shareholder and SEC approval.

Portfolio Pulse from Benzinga Newsdesk

October 29, 2024 | 1:48 pm

LLY

Eli Lilly Canada has successfully completed negotiations with the pan-Canadian Pharmaceutical Alliance for the expanded indication of Verzenio in early breast cancer treatment. This follows a positive recommendation from Canada's Drug Agency.

Portfolio Pulse from Benzinga Newsdesk

October 29, 2024 | 1:33 pm

POCI

Precision Optics' customer has received FDA 510(k) clearance, which could positively impact Precision Optics due to potential increased demand for their products.

Portfolio Pulse from Benzinga Newsdesk

October 29, 2024 | 1:12 pm

TSLA

The U.S. has announced a ban on investments in China's semiconductor and AI sectors, potentially affecting Tesla's operations in the region. This move aims to prevent American capital from enhancing China's military capabilities. The ban could impact Tesla's AI plans, including a data center in China, and delay the launch of its Full Self-Driving technology.

Portfolio Pulse from Pooja Rajkumari

October 29, 2024 | 1:10 pm

MCD

McDonald's has addressed an E. coli outbreak by taking swift and decisive action, as stated by a company executive. This response is crucial for maintaining customer trust and ensuring food safety.

Portfolio Pulse from Benzinga Newsdesk

October 29, 2024 | 12:57 pm

LSB

LakeShore Biopharma has regained compliance with Nasdaq's minimum bid price requirement, as confirmed by a notice from Nasdaq's Listing Qualifications Department.

Portfolio Pulse from Benzinga Newsdesk

October 29, 2024 | 12:39 pm

ICCM

IceCure Medical announced that numerous public comments from key stakeholders have been posted ahead of the FDA Advisory Panel meeting on November 7, 2024, for the marketing authorization of its ProSense Cryoablation System for early-stage low-risk breast cancer.

Portfolio Pulse from Benzinga Newsdesk

October 29, 2024 | 12:39 pm

QTI

QT Imaging Holdings, Inc. (NASDAQ:QTI) has received a renewal for the third year of its five-year NIH-sponsored study. The study aims to develop a portable breast imaging system for early identification of breast cancer response to chemotherapy.

Portfolio Pulse from Benzinga Newsdesk

October 29, 2024 | 12:38 pm